• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Report: Pharma companies ask Supremes to take eye-dropper case

April 2, 2018 By Sarah Faulkner

GavelA group of pharmaceutical companies, including Allergan (NYSE:AGN) and Merck (NYSE:MRK), have asked the Supreme Court to review a case between the industry players and patients regarding the design of the companies’ eye-droppers, according to a report from the AP.

In the on-going legal debate, patient groups have claimed that the companies’ devices dispense large drops of medication that overwhelm the eye and ultimately waste expensive drug product. The users also allege that if the bottle was properly designed to dispense smaller drops of medicine, they would pay less.

The companies have pushed back, arguing that patients can’t sue in federal court based on a theoretical eye-dropper. They also shouldn’t be allowed to hypothesize how much money a redesigned bottle would save them, according to the report.

The pharmaceutical companies pointed out that a new bottle would have to be cleared by the FDA, which could possibly result in establishing a larger price-tag to recoup the costs linked with landing regulatory approvals.

The courts haven’t reached a decision over whether the patient groups can sue the drugmakers; a federal appeals court in Chicago threw out an eye-dropper lawsuit, while a federal appeals court in Philadelphia allowed a similar case to move forward.

One advocate representing the drug companies told the AP that the eye-dropper lawsuit could open the floodgates to other design-related cases, like a lawsuit brought by “toothpaste users whose tubes of toothpaste did not allow every bit of toothpaste to be used,” Kannon Shanmugam told the news outlet.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

 

Filed Under: Drug-Device Combinations, Featured, Legal News, Optical/Ophthalmic, Pharmaceuticals, Wall Street Beat Tagged With: Allergan, Merck, Pfizer Inc.

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS